Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
Brigham and Women's Hospital
400 participants
Dec 17, 2024
INTERVENTIONAL
Conditions
Summary
This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Eligibility
Inclusion Criteria3
- Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
- Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
- Access to a basic telephone
Exclusion Criteria2
- Patients who underwent allogeneic HSCT for benign hematologic conditions
- Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PATH, a phone-delivered positive psychology intervention for patients who have undergone HSCT, consists of three 3-week modules. The first module focuses on gratitude and physical activity goal setting. The second module focuses on personal strengths and resources to enhance daily physical activity. The third module focuses on meaning and assessing barriers to physical activity. The third week of each module is an integration exercise dedicated to help participants explore practical ways of incorporating the themes for the given module into daily life. A trained interventionist will guide participants to complete each 30-minute weekly session.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06328127